Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Radial Extracorporeal Shockwave Therapy in Individuals With Iliotibial Band Syndrome

NCT: NCT07668011 · RECRUITING

NCT IDNCT07668011
StatusRECRUITING
Start Date2026-06-10
Completion2026-08-30
SponsorCairo University (OTHER)
First posted
Last updated

Brief Summary

The goal of this Clinical Trial Study is to evaluate the clinical effectiveness of Radial Electrocorporeal Shockwave Therapy (rESWT) combined with exercise in individuals with iliotibial band syndrome (ITBS).The main question it aims to answer is : Does the addition of rESWT to standard ITBS exercise program reduce pain intensity and pain pressure threshold while improving lower extremity function and hip muscle strength in Individuals with Iliotibial Band syndrome (ITBS). Participants will be divided into two groups to be compared : The ShamTherapy Group (Control Group) that will receive the standard ITBS exercise program in addition to Sham rESWT, while the experimental group will receive the standard ITBS exercise program in addition to Radial Extracorporeal Shockwave Therapy.

Frequently Asked Questions

What is Radial Extracorporeal Shockwave Therapy in Individuals With Iliotibial Band Syndrome?

Radial Extracorporeal Shockwave Therapy in Individuals With Iliotibial Band Syndrome is a clinical trial registered under NCT07668011. Current status: RECRUITING.

What is the status of NCT07668011?

The current status of NCT07668011 (Radial Extracorporeal Shockwave Therapy in Individuals With Iliotibial Band Syndrome) is: RECRUITING.

When did Radial Extracorporeal Shockwave Therapy in Individuals With Iliotibial Band Syndrome start?

Radial Extracorporeal Shockwave Therapy in Individuals With Iliotibial Band Syndrome started on 2026-06-10.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.